← Back to Clinical Trials
Recruiting NCT07431983

NCT07431983 Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07431983
Status Recruiting
Phase
Sponsor Asian Institute of Gastroenterology, India
Condition Ulcerative Colitis (UC)
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2026-03-01
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2026-03-01 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Healthcare contributes approximately 4.4% of global GHG emissions, with diagnostic imaging and endoscopic services being substantial contributors. Colonoscopy and cross-sectional imaging modalities, though indispensable, are associated with high carbon emissions due to electricity use, waste, sterilisation, and transportation. IBUS, a non-invasive, real-time diagnostic modality, is increasingly validated for disease activity assessment in both UC and CD.

Eligibility Criteria

All consecutive patients undergoing endoscopy procedures with consent for procedures, during the study period will be included

Contact & Investigator

Central Contact

Dr.Hardik Rughwani

✉ dr.hardikr@aighospitals.com

📞 9426928600

Frequently Asked Questions

Who can join the NCT07431983 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Ulcerative Colitis (UC). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07431983 currently recruiting?

Yes, NCT07431983 is actively recruiting participants. Contact the research team at dr.hardikr@aighospitals.com for enrollment information.

Where is the NCT07431983 trial being conducted?

This trial is being conducted at Hyderabad, India, Hyderabad, India.

Who is sponsoring the NCT07431983 clinical trial?

NCT07431983 is sponsored by Asian Institute of Gastroenterology, India. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology